Dr. Michael Leapman presented “How Should We Monitor Patients During Surveillance?” at...Read More
Michael Leapman, MD
Yale University School of Medicine
New Haven, CT
Michael Leapman, MD was drawn to the field of urology for the opportunity to care for patients with urologic cancers. Dr. Leapman graduated from Cornell University where he majored in Neurobiology and Behavior, and received his medical school degree from the University of Maryland in Baltimore. He completed his General Surgery and Urology training at the Mount Sinai Hospital in New York, NY. Subsequently, he completed a two-year urologic oncology fellowship at the University of California San Francisco (UCSF) accredited by the Society of Urologic Oncology. He was recruited to join the faculty at the Yale University School of Medicine Smilow Cancer Center in 2016, specializing in urologic oncology with a joint appointment at the West Haven Veterans Affairs Medical Center. His clinical interests include low-risk prostate cancer, active surveillance, nerve-sparing robotic prostatectomy, focal therapy, high-risk disease, and pelvic lymph node dissection.
Articles by Michael Leapman, MD
Posted by Michael Leapman, MD | May 2017
Dr. Michael Leapman presented “Can Genomics Improve Upon Best Clinical Risk...Read More